Found: 7
Select item for more details and to access through your institution.
Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasia.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.954567
- By:
- Publication type:
- Article
The 4717C > G polymorphism in periplakin modulates sensitivity to EGFR inhibitors.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-38742-0
- By:
- Publication type:
- Article
IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells.
- Published in:
- Cellular Oncology (2211-3428), 2019, v. 42, n. 4, p. 477, doi. 10.1007/s13402-019-00437-z
- By:
- Publication type:
- Article
Valproic acid: Growth inhibition of head and neck cancer by induction of terminal differentiation and senescence.
- Published in:
- Head & Neck, 2012, v. 34, n. 3, p. 344, doi. 10.1002/hed.21734
- By:
- Publication type:
- Article
Effects of palbociclib on oral squamous cell carcinoma and the role of PIK3CA in conferring resistance.
- Published in:
- Cancer Biology & Medicine, 2019, v. 16, n. 2, p. 264, doi. 10.20892/j.issn.2095-3941.2018.0257
- By:
- Publication type:
- Article
DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.763086
- By:
- Publication type:
- Article
Synergistic Growth Inhibition by Afatinib and Trametinib in Preclinical Oral Squamous Cell Carcinoma Models.
- Published in:
- 2019
- By:
- Publication type:
- journal article